News

<>

May 15, 2017

Scrip

Entresto Facing Pressure From Diabetes Drugs

By Lucie Ellis

With diabetes therapeutics adding cardiovascular risk reduction claims, Novartis’s heart failure drug Entresto could face pressure from new fronts – just as sales start to take off.

read full article >